FDA Grants Full Approval To Pfizer COVID-19 Vaccine
www.thepulse.one
What Happened: On Monday, The Food and Drug Administration granted full approval to Pfizer-BioNTech’s COVID-19 vaccine for people aged 16 and up. This is the first COVID-19 vaccine to move out of emergency use status in the United States. In order to get approval, Pfizer claims it provided the F.D.A. with data from 44,000 clinical trial participants in United States, the European Union, Turkey, South Africa and South America. Pfizer claims their data shows the vaccine was 91 percent effective in preventing infection.
FDA Grants Full Approval To Pfizer COVID-19 Vaccine
FDA Grants Full Approval To Pfizer COVID-19…
FDA Grants Full Approval To Pfizer COVID-19 Vaccine
What Happened: On Monday, The Food and Drug Administration granted full approval to Pfizer-BioNTech’s COVID-19 vaccine for people aged 16 and up. This is the first COVID-19 vaccine to move out of emergency use status in the United States. In order to get approval, Pfizer claims it provided the F.D.A. with data from 44,000 clinical trial participants in United States, the European Union, Turkey, South Africa and South America. Pfizer claims their data shows the vaccine was 91 percent effective in preventing infection.